Our Current Trials

Condition	Trial Name	Sponsor
Ovarian Cancer	AVB-S6-500 in Combination With Paclitaxel vs Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer	Aravive, Inc.
Non-Small Cell Lung Cancer	AdvanTIG-205: Ociperlimab and Tislelizumab as First-Line Treatment in the Metastatic Setting	BeiGene, Ltd.
Non-Small Cell Lung Cancer	AdvanTIG-301: Ociperlimab Plus Tislelizumab Plus Concurrent Chemoradiotherapy in Stage 3 NSCLC	BeiGene, Ltd.
Colon or Rectal Adenocarcinoma	BREAKWATER: First Line Encorafenib + Cetuximab +/- Chemotherapy in Patients Whose Tumors Express a BRAF V600E mutation	Pfizer
Chemotherapy-Induced Oral Mucositis	Chemo Mouthpiece Medical Device Trial	Chemo Mouthpiece, LLC
Solid Tumors	Clovis LODESTAR: Rucaparib in HRD Mutated Solid Tumors	Clovis Oncology, Inc.
Ovarian Cancer	EP0057-201: A Phase 2 study to evaluate the safety and efficacy of EP0057 in combination with olaparib	Ellipses Pharma
Advanced or Metastatic Solid Tumors	Exelixis: Cabozantinib plus Atezolizumab for Subjects with Locally Advanced or Metastatic Solid Tumors	Exelixis
Urothelial Carcinoma	FIDES-02: Derzantinib for Patients with a Mutation in FGFR1-3	Basilea Pharmaceutica
Solid Tumors	KEYLYNK-007: Nivolumab plus Olaparib for Patients with HRR Mutated Solid Tumors	Merck Sharp & Dohme Corp.
Prostate Cancer	KPG-121 in Castration Resistant Prostate Cancer	Kangpu Biopharmaceuticals, Ltd.
Colon or Rectal Cancer	KRYSTAL-10: Adagrasib in KRAS G12C Mutated Colorectal Cancer	Mirati Therapeutics, Inc.
Non-Small Cell Lung Cancer	LEAP-008: Lenvatinib and Pembrolizumab after Platinum and Immunotherapy	Merck Sharp & Dohme Corp.
Colon or Rectal Cancer	LUT014 Gel for EGFR-Inhibitor Induced Acneiform Rash	Lutris Pharma Ltd.
Solid Tumors	MyTACTIC: Multiple Cohort Solid Tumor Trial	Genentech, Inc.
Hyperkalemia/Chronic Kidney Disease	NYH-01: Hyperkalemia/Chronic Kidney Disease	Relypsa
Solid Tumors	OnTARGET: Crofelemer for Diarrhea Prophylaxis in Patients Receiving Targeted Therapy	Napo Pharmaceuticals
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome	PRT1419-03: PRT1419 in Patients with Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndrome	Prelude Therapeutics
Non-Small Cell Lung Cancer	SAPPHIRE: Second Line Sitravatinib Plus Nivolumab	Mirati Therapeutics, Inc.
Non-Small Cell Lung Cancer	SPI-POZ-202: Poziotinib for EGFR/HER2 Exon 20 Mutated Non-Small Cell Lung Cancer	Spectrum Pharmaceuticals, Inc.
Non-Small Cell Lung Cancer	TROPION-Lung05: DS-1062a in NSCLC with actionable genetic mutations	Daiichi Sankyo, Inc.
Oropharyngeal Cancer	VOICE: Clonidine Mucoadhesive Buccal Tablet for Chemoradiotherapy-Induced Oral Mucositis	Monopar Therapeutics Inc.
Solid Tumor or Lymphoma	ZL-1201-001: Trial of ZL-1201 in Subjects With Advanced Cancer	Zai Lab (Shanghai) Co., Ltd.
Non-Small Cell Lung Cancer	ZN-e4-001: Zn-e4 in EGFR mutated NSCLC	Zeno Pharmaceuticals, Inc.
Myelodysplatic Syndrome or Acute Myeloid Leukemia	[Registry] An Observational Study to Collect and Assess Tissue Samples from Subjects With Documented Hematologic Malignancy (ANSWer)	Notable Labs
Non-Small Cell Lung Cancer, Colorectal Cancer, Melanoma	[Registry] BESPOKE IO: Study of ctDNA Guided Immunotherapy	Natera, Inc.
Cutaneous Squamous Cell Carcinoma	[Registry] CemiplimAb in Cutaneous Squamous Cell Carcinoma (CASE)	Regeneron Pharmaceuticals, Inc.
Prostate Cancer	[Registry] Trial Evaluating the RadTox Assay for Predicting GI Toxicity Associated with Radiation Therapy	DiaCarta, Inc.
Breast Cancer, Non-Small Cell Lung Cancer	[Registry] Use of a Smartphone Application to Improve Anxiety and Depression Symptoms in Cancer Patients	Blue Note Therapeutics, Inc.
Solid Tumors	[Sample Collection] A Prospective Blood Sample Collection Study to Evaluate a Panel of Protein-based Biomarkers (SEERPRO)	Seer, Inc.
Various Indications	[Sample Collection] Clinical Biospecimen Procurement Protocol to Support Advancements in Medical Diagnoses of Diseases (PROMEDx)	Precision for Medicine
Solid Tumors	[Sample Collection] Collection and Distribution of Biofluids for Research Purposes	Bluestar Genomics
Solid Tumors	[Sample Collection] Detecting cancers Earlier Through Elective plasma-based Cancer SEEK Testing (DETECT-ASCEND 2)	Exact Sciences Thrive LLC
Various Indications	[Sample Collection] Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients (MTG-022)	MT Group
Various Indications	[Sample Collection] Prospective Collection of Samples for Research (SERATRIALS-05035)	SERATRIALS, LLC.

Our Current Trials

Call Us

COVID-19 - Information